Patients with T2D and obesity are thought to have a higher risk of developing complications from COVID-19 due to underlying chronic inflammation affecting glucose regulation and insulin sensitivity. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.